Rosuvastatin intensifies the beneficial effects of rho-kinase inhibitor in reversal of monocrotaline-induced pulmonary hypertension
Submission date: 2014-09-22
Final revision date: 2014-11-21
Acceptance date: 2014-11-24
Online publication date: 2015-05-22
Publication date: 2016-06-30